Small-Molecule Inhibitors of Histone Acetyltransferase Activity: Identification and Biological Properties-Reference-Cited by-同舟云学术

Small-Molecule Inhibitors of Histone Acetyltransferase Activity: Identification and Biological Properties

Published:2006-10-17 Issue:23 Volume:49 Page:6897-6907
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mai Antonello¹,Rotili Dante¹,Tarantino Domenico¹,Ornaghi Prisca¹,Tosi Federica¹,Vicidomini Caterina¹,Sbardella Gianluca¹,Nebbioso Angela¹,Miceli Marco¹,Altucci Lucia¹,Filetici Patrizia¹

Affiliation:

1. Dipartimento di Studi Farmaceutici, Istituto PasteurFondazione Cenci Bolognetti, Università degli Studi di Roma “La Sapienza”, P.le A. Moro 5, 00185 Roma, Italy, Dipartimento di Genetica e Biologia Molecolare, Università degli Studi di Roma “La Sapienza”, P.le A. Moro 5, 00185 Roma, Italy, Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, Via Ponte Don Melillo, 84084 Fisciano (SA), Italy, Dipartimento di Patologia Generale, Seconda Università degli Studi di Napoli, Vico L. De...

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm060601m

Reference74 articles.

1. Covalent modifications of histones: expression from chromatin templates

2. Histone acetylases and deacetylases in cell proliferation

3. The language of covalent histone modifications

4. What's Up and Down with Histone Deacetylation and Transcription?

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

2. 2-Azidobenzaldehyde-Based [4+2] Annulation for the Synthesis of Quinoline Derivatives;Molecules;2024-03-11

3. Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy;Trends in Pharmacological Sciences;2024-03

5. Acetyl-CoA metabolism as a therapeutic target for cancer;Biomedicine & Pharmacotherapy;2023-12